Epidemiological studies consistently correlate high PM2.5 levels with increased asthma incidence and exacerbation rates, positioning the AIM2 inflammasome as a potential therapeutic target for pollutant-associated airway injury (27). The gene discussed is AIM2; the disease is asthma.